Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer

NCT00004186 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: etoposide
DRUG: ifosfamide
DRUG: topotecan hydrochloride
RADIATION: radiation therapy

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]